Sign up

Perioperative Durvalumab Improves Survival

Clinical caseOncology2 min
Perioperative Durvalumab Improves Survival

An adult with histologically documented resectable gastric adenocarcinoma is eligible for radical surgery and has not previously received anticancer therapy. You are considering perioperative systemic treatment options.

For a patient like this, what does the evidence in this abstract support?